- Open Access
Plasmodium vivax HAP2/GCS1 gene exhibits limited genetic diversity among parasite isolates from the Greater Mekong Subregion
Parasites & Vectors volume 13, Article number: 175 (2020)
Antigens expressed in sexual stages of the malaria parasites are targets of transmission-blocking vaccines (TBVs). HAP2/GCS1, a TBV candidate, is critical for fertilization in Plasmodium. Here, the genetic diversity of PvHAP2 was studied in Plasmodium vivax parasite populations from the Greater Mekong Subregion (GMS).
Plasmodium vivax clinical isolates were collected in clinics from the China-Myanmar border region (135 samples), western Thailand (41 samples) and western Myanmar (51 samples). Near full-length Pvhap2 (nucleotides 13–2574) was amplified and sequenced from these isolates. Molecular evolution studies were conducted to evaluate the genetic diversity, selection and population differentiation.
Sequencing of the pvhap2 gene for a total of 227 samples from the three P. vivax populations revealed limited genetic diversity of this gene in the GMS (π = 0.00036 ± 0.00003), with the highest π value observed in Myanmar (0.00053 ± 0.00009). Y133S was the dominant mutation in the China-Myanmar border (99.26%), Myanmar (100%) and Thailand (95.12%). Results of all neutrality tests were negative for all the three populations, suggesting the possible action of purifying selection. Codon-based tests identified specific codons which are under purifying or positive selections. Wright’s fixation index showed low to moderate genetic differentiation of P. vivax populations in the GMS, with FST ranging from 0.04077 to 0.24833, whereas high levels of genetic differentiation were detected between the China-Myanmar border and Iran populations (FST = 0.60266), and between Thailand and Iran populations (FST = 0.44161). A total of 20 haplotypes were identified, with H2 being the abundant haplotype in China-Myanmar border, Myanmar and Thailand populations. Epitope mapping prediction of Pvhap2 antigen showed that high-score B-cell epitopes are located in the S307-G324, L429-P453 and V623-D637 regions. The E317K and D637N mutations located within S307-G324 and V623-D637 epitopes slightly reduced the predicted score for potential epitopes.
The present study showed a very low level of genetic diversity of pvhap2 gene among P. vivax populations in the Greater Mekong Subregion. The relative conservation of pvhap2 supports further evaluation of a Pvhap2-based TBV.
Malaria remains an important public health problem in the six countries of the Greater Mekong Subregion (GMS), including Cambodia, China’s Yunnan and Guangxi provinces, Lao PDR, Myanmar, Thailand and Vietnam . Launching of the malaria elimination programme in the GMS has led to a steady decline of malaria burden in the GMS in recent years . However, this ambitious plan encounters multiple challenges such as antimalarial multidrug resistance, cross-border population mobility and parasite introduction, and asymptomatic Plasmodium infections as the reservoir for malaria transmission [3,4,5,6]. In addition, Plasmodium vivax has become the predominant parasite in the GMS, and its proportion has been increasing . Thus, new and integrated intervention strategies to reduce malaria transmission are needed. Among them, transmission-blocking vaccines (TBVs) are considered an integral component of the measures for malaria control and elimination [8,9,10,11].
Gametocytes developed in the human host are the obligative stage for the transmission to mosquitoes . After a mosquito takes an infected blood meal, male and female gametocytes are activated in the mosquito midgut to develop into gametes. Fertilization between a microgamete and a macrogamete produces a zygote, which then transforms into a mobile ookinete. The ookinete traverses the mosquito midgut wall and starts sporogonic development in the mosquito. Although the molecular mechanisms of fertilization are poorly understood, this process is a promising target for the interruption of transmission . Several proteins involved in the fertilization process have been identified, including P47, P48/45, P230 and HAP2 [14, 15]. HAP2/Generative Cell Specific 1 (GCS1), first identified in the plants Arabidopsis thaliana and Lilium longflorum, is a class II viral fusion protein with a cysteine-rich extracellular region [16,17,18]. HAP2/GCS1 is highly conserved in a wide range of species, such as the green alga Chlamydomonas and Plasmodium . The N-terminus of this protein interacts with proteins expressed on the female gamete, whereas the C-terminus interacts with sperm plasma membrane during fertilization . In Plasmodium, HAP2 protein is located specifically on the surface of activated male gametes [18, 19]. It is an essential component for gamete fusion, since hap2 gene knockout in the rodent parasite P. berghei abolishes fertilization [19, 21]. Recent studies identified a conserved ‘cd loop’ segment within the HAP2/GCS1 protein, corresponding to amino acids (aa) 174–205 in PbHAP2 and aa 178–207 in P. falciparum HAP2, which is critical for membrane fusion during fertilization [16, 22, 23]. Antibodies raised against ‘cd loop’ segment of both PbHAP2 and PfHAP2 protein showed evident transmission reduction activity (TRA) in mosquito feeding assays [21, 24]. Meanwhile, like other surface-located vaccine candidate antigens, naturally acquired antibodies against HAP2 are detected in malaria exposed individuals . Altogether, these results suggest that HAP2 is a promising TBV candidate.
Understanding the genetic diversity of a vaccine candidate in endemic areas is necessary for guiding the development of an effective malaria vaccine. Genetic polymorphism in vaccine candidates for asexual stages of malaria parasites has been a major limiting factor for the development of malaria vaccines . Thus, the genetic diversity, natural selection, population differentiation and haplotype prevalence of Pvhap2 in P. vivax populations from the GMS were assessed in this study. These analyses revealed limited genetic diversity of Pvhap2 gene as well as little differentiation of parasite populations in the GMS compared with the global sequences of a gamete fertilization essential gene, so as to provide useful information for transmission blocking vaccine development.
Plasmodium vivax clinical isolates
A total of 135, 51 and 41 clinical parasite isolates were collected from patients with acute P. vivax malaria attending clinics located in the China-Myanmar border area (Laiza Township, Kachin State, Myanmar and Nabang Township, Yunnan Province, China) in 2016, western Myanmar (Paletwa Township, Chin State) in 2018, and western Thailand (Tha Song Yang District, Tak Province) in 2011, respectively (Additional file 1: Figure S1). The distances among three sampling sites are similar (1275–1450 km). Plasmodium vivax infections were diagnosed by microscopical examination of Giemsa-stained thin and thick blood smears. Filter paper blood spots from finger-prick were prepared and stored individually in sealed plastic bags. Written informed consent was obtained from all participants and guardians of children.
Genomic DNA extraction, PCR and sequencing of the pvhap2 gene
Genomic DNA (gDNA) was extracted from dried filter blood spots by using the QIAamp DNA mini kit (Qiagen, Hilden, Germany) and stored at − 20 °C until use. Primers for pvhap2 gene amplification were designed using the pvhap2 sequence (PlasmoDB ID: PVX_094925), located on chromosome 8 at nucleotides 651,355 to 654,032 of the P. vivax Salvador-I (Sal I) reference strain (Additional file 2: Table S1). The pvhap2 sequence corresponding to nucleotides 13–2574 (aa 5–858) was amplified by PCR using the primer pair pvsHap2-1F and pvsHap2-1R for the primary PCR, and the primer pair pvsHap2-nest-F and pvsHap2-nest-R for the nested PCR. Primary and nested PCR was conducted in a reaction volume of 20 μl including 1× KOD-Plus-Neo buffer (Toyobo, Osaka, Japan), 200 μM dNTPs (Toyobo), 1 mM MgSO4 (Toyobo), 10 µM of each primer, 1 μl of gDNA or primary PCR product (1:1000 dilution), and 0.4 units of KOD-Plus-Neo DNA polymerase (Toyobo). The cycling conditions for both primary and nested PCR were as follows: one step at 95 °C for 5 min; 39 cycles at 95 °C for 30 s, 55 °C for 15 s, and 68 °C for 1 min; and an extension step at 68 °C for 5 min. The PCR products were separated in 1.5% agarose gel in the presence of SYBRTM Safe DNA (Thermo Fisher Scientific, Waltham, USA) and visualized under UV light. PCR fragments were purified with QIAquick PCR Purification kit (Qiagen) according to the manufacturer’s protocol and sequenced in both directions using primers listed in Additional file 2: Table S1 on a 3730XL DNA analyzer (Applied Biosystems, Waltham, USA). To verify the sequencing accuracy, purified PCR products from two independent amplifications of each isolate were sequenced in both DNA strands. Sequencing results of samples with double peaks at one single site were considered as mixed infection and excluded from further analysis. All nucleotide singletons (substitutions appearing only once among the sequences) were re-sequenced from new PCR products for verification. The nucleotide sequences were deposited in the GenBank database under the accession numbers MT087312-MT087446 (China-Myanmar border), MT087488-MT087538 (Myanmar) and MT087447-MT087487 (Thailand). In addition, 52 pvhap2 sequences from Iranian P. vivax isolates (GenBank: KM594259-KM594288 and KU743361-KU743382) were included for comparison .
Genetic diversity and natural selection
Pvhap2 sequences were aligned using Clustal W program in MEGA X . The number of segregation sites (S), total number of mutations (η), nucleotide diversity (π), the average number of nucleotide differences (k), number of haplotypes (H), haplotype diversity (Hd) and the corresponding standard deviation were computed using DnaSP v6.10.01 . Additionally, nucleotide diversity was also estimated on a sliding window of 90 bases with a step size of 3 bp implemented in DnaSP v6.10.01 . Natural selection was determined by calculating the dN-dS difference using the Nei & Gojobori’s method with the Jukes & Cantor correction as implemented in MEGA X, and significance was determined by a Z-test . A positive value of dN-dS shows positive natural selection, whereas a negative value indicates purifying selection. The Tajima’s D test , Fu & Liʼs D* and F* tests  were performed using DnaSP v6.10.01 to determine departure from neutrality . McDonald-Kreitman (MK) test  was performed using the Plasmodium cynomolgi hap2 gene (PlasmoDB ID: PcyM_0814900) as an outgroup . Meanwhile, to detect selection acting on specific amino acids of the protein, codon-based test was performed by using HyPhy package implemented in the Data Monkey Web Server . Fisher’s exact test was applied to test for significant non-randomness (P < 0.05), and the skew from randomness was calculated as the neutrality index.
Genetic differentiation, haplotype network and phylogenetic analysis
The genetic differences between populations was investigated by estimating the rate of fixation (FST) implemented in ARLEQUIN v220.127.116.11 software . Interpretation of FST values is defined as no differentiation (0), low genetic differentiation (≤ 0.15), moderate genetic differentiation (0.15–0.25) and high differentiation (≥ 0.25) . P-value < 0.05 was considered as indicating a significant difference. The median-joining method in NETWORK v18.104.22.168  was used to establish genealogical relationship of the Pvhap2 haplotypes among the parasite populations. A phylogenetic tree was constructed using the neighbor joining method in MEGA X software with a bootstrap of 1000 pseudo-replicates .
Prediction of linear B cell and T cell epitopes
The potential B cell epitopes of Pvhap2 were predicted by using the ABCpred server  and BepiPred (http://www.cbs.dtu.dk/services/BepiPred/). For ABCpred server, a threshold of 0.7 was used to predict a peptide length of 16 residues. The program BepiPred was run with an epitope threshold of 0.6, and the epitope score represents the average of the scores of at least eight consecutive amino acids above the cut-off. The overlapped predicted regions from ABCpred and BepiPred, as well as mutation sites were marked on the schematic structure of Pvhap2 protein by using DOG 2.0 software [37, 38]. The 3D structure of the full-length Pvhap2 was predicted using the Phyre2 algorithm . The electrostatic potential of Pvhap2 3D structure was calculated with the Adaptive Poisson-Boltzmann Solver software integrated with Pymol2.3 program . The amino acid sequence of Pvhap2 in the Sal I strain (PlasmoDB ID: PVX_094925) was used.
Polymorphism in the pvhap2 gene
We sequenced the almost full-length pvhap2 gene (nt 13–2574 bp) in 227 clinical P. vivax samples collected from three regions of the GMS. From the alignment with the reference Sal I strain, 28 single nucleotide polymorphisms (SNPs) were identified. Among them, 16 SNPs were synonymous and 12 were non-synonymous (Table 1). The dominant non-synonymous mutation Y133S reached or almost approached fixation in the three populations, with a frequency of 99.3, 100 and 95.1% in the China-Myanmar border, Myanmar and Thailand populations, respectively (Table 2). In addition, D637N was detected with high frequencies of 83.0, 36.5 and 68.3% in the China-Myanmar border, Myanmar and Thailand populations, respectively (Table 1). Other non-synonymous mutations were present in 0.74–7.84% of pvhap2 sequences of the three populations (Table 1). Among the 12 synonymous mutations, A2636C (R849R) was present in 100% the parasites from the GMS (Table 1). Of note, no SNPs were observed in the putative functionally essential HAP2-GCS1 domain (codons 338–397 aa) of pvhap2 gene (Table 1).
The overall nucleotide diversity (π) for the 227 pvhap2 sequences was low at 0.00036 ± 0.00003 (Table 2). The highest nucleotide diversity was observed in western Myanmar (0.00053 ± 0.00009), followed by Thailand (0.00043 ± 0.00007) and China-Myanmar border population (0.00023 ± 0.00003) (Table 2). Similarly, parasites from western Myanmar presented the highest haplotype diversity (Hd = 0.747 ± 0.057), whereas parasites from the China-Myanmar border showed the lowest Hd (0.420 ± 0.052) (Table 2). Sliding window plots of nucleotide diversity revealed π value distributed unevenly in pvhap2 gene, with the highest π value detected in 1875–1953 bp region of the all three parasite populations (Fig. 1). Three (YNQD, SNQD and SNQN) out of five commonly observed global haplotypes of Pvhap2 according to the four amino acid replacements (Y133S, N575S, Q634P and D637N) were observed in these populations (Table 3). Of these, ‘SNQN’ was the most frequent haplotype in the China-Myanmar border (85.19%) and Thailand (68.29%) populations, while ‘SNQD’ was the common haplotype in Myanmar (62.75%) (Table 3). However, the Sal I type haplotype ‘YNQD’ was not observed in Myanmar, and was observed at very low frequencies in the China-Myanmar border (0.74%) and Thailand (2.44%) (Table 3).
When the pvhap2 gene (nt 397–2097 bp) obtained from this study was aligned with previously published global pvhap2 sequences , the highest average number of pairwise nucleotide (k) value was observed in the China isolates (1.267), followed by Thailand (0.963) and Myanmar (0.897) isolates, while the lowest k-value was detected in the PNG isolates (0.286) (Additional file 3: Table S2). Meanwhile, China and Thailand samples were found to have much higher nucleotide diversity and haplotype diversity (China, π = 0.00075 and Hd = 0.733 ; Thailand, π = 0.00057 and Hd = 0.668) than other global isolates (Additional file 3: Table S2).
Evidence of natural selection
Several neutrality tests were performed to examine if the pvhap2 gene was under selection. Except the China-Myanmar border isolates, which showed dN = dS, negative values for dN-dS were obtained for both Myanmar (− 0.0002) and Thailand (− 0.0003) populations; however, neither value was statistically significant by Fisher’s exact test (Table 5). Significant negative value of Tajima’s D (− 1.9897, P < 0.05) observed in Myanmar isolates indicated purifying or directional selection (Table 4). Although Tajima’s D value was also below zero in the China-Myanmar border and Thailand populations, the tests showed no significant departure from neutrality (Table 4). In comparison, both Fu & Li’s D* and F* tests identified significant deviation from zero in pvhap2 genes in the three populations, suggesting expansion in population size and/or purifying selection (Table 4). Consistent results were obtained with the McDonald-Kreitman’s test using the P. cynomolgi hap2 gene as the outgroup, which showed an excess of synonymous substitutions within the pvhap2 sequences relative to synonymous substitutions from the outgroup species, albeit the result was significant only in China-Myanmar border population, suggesting functional constraint occurring at certain residues in this protein (Table 4).
The codon-based tests for selection were performed on pvhap2 gene by using FEL , SLAC , and FUBAR  implemented in the Datamonkey webserver . The likelihood-based algorithms (FUBAR method) revealed purifying selection at 640, 756 and 849 codons in the China-Myanmar border isolates (Table 5). Meanwhile, purifying selection was also detected by the FEL method in the Myanmar isolates at 61, 179, 246 and 513 codons (Table 5). The FUBAR method detected both positive and purifying selections in the Myanmar isolates at specific codons (positively selected sites: 129, 637 and 684; purifyingly selected sites: 61, 179, 236, 429, 513, 573, 640, 761 and 849) (Table 5). It is noteworthy that D637N was a prevalent mutation in the Myanmar population, reaching a frequency of 36.54% (Table 1). Whereas no positive selection was detected in the Thailand population with all the three methods, only purifying selection was detected at 765 and 849 codons by the FEL method, and at 316, 640, 756, 765 and 849 codons by the FUBAR method (Table 5).
Pairwise comparisons were performed using the Wright’s fixation index (FST) to study genetic differentiation between parasite populations. AMOVA revealed statistically significant differences in all studied populations. The pairwise comparison of parasite populations between the China-Myanmar border and Thailand populations, as well as between the Thailand and Myanmar populations showed little genetic differentiation with an FST value of 0.04077 and 0.09271, respectively (Table 6). Moderate genetic differentiation was observed between the China-Myanmar border and western Myanmar populations, and between Iran and Myanmar populations, with an FST value of 0.24833 and 0.19226, respectively (Table 6). In contrast, high-level genetic differentiation was detected between the China-Myanmar border and Iran populations (FST = 0.60266), as well as between Thailand and Iran populations (FST = 0.44161), suggesting a high degree of differentiation between Southeast and West Asia populations.
Haplotype network and phylogeny
Haplotype network analysis showed that among 20 haplotypes of 279 pvhap2 sequences obtained from the China-Myanmar border, western Myanmar, Thailand and Iran isolates, 60% (12/20) was represented by single parasite isolates (Fig. 2). Two major haplotypes H2 and H3 were most abundant, with a frequency of 50 and 35.7%, respectively (Fig. 2). H2 was shared among the three GMS parasite populations and reached a frequency of 77.0% in the China-Myanmar border population. H3 was shared among the three GMS and the Iran parasite populations and reached 88.2% (45/51) in the Iran parasite population. The prevalence of other haplotypes ranged from 0.4 to 2.5%. Parasites with the Sal I reference haplotype (H1) had a 2.1% prevalence, which was present in the China-Myanmar border, Thailand and Iran parasite populations with a frequency of 0.7%, 7.3% and 1.9%, respectively (Fig. 2).
Phylogenetic analysis revealed that the haplotypes were clustered into three main groups with Group I consisting of 10 haplotypes, Group II consisting of 4 haplotypes, and Group III consisting of 6 haplotypes (Fig. 3). It is interesting to note that the neighbor-joining consensus tree for pvhap2 revealed geographical clustering by countries or regions, with the Iran haplotypes only observed in Group I, whereas 75% of Group II haplotypes was unique to the western Myanmar population, and Group III consisted of admixed haplotypes from the three GMS populations (Fig. 3).
Polymorphisms associated with B and T cell epitopes
The secondary structure of deduced amino acid sequence of Pvhap2 was analyzed by using the Pymol software. Most residues, including K129, Y133, Q224, E317, G542, N575 and D637 are predicted to be exposed to the surface, except Q224 which would be hidden inside the negative pocket (Fig. 4a). All the mutation sites belonged to flexible loop structures (Fig. 4a). Three overlapped peptides (S307-G324, L429-P453, V623-D637) were predicted to be B epitopes from the BepiPred and ABCpred software. The prediction scores for the three epitopes (S307-G324, L429-P453 and V623-D637) were 0.65, 0.63, and 0.63, respectively. Two non-synonymous mutations were found in these predicted B cell linear epitopes (E317K and D637N), which resulted in slight decreases of the predicted scores for the epitopes (Fig. 4b).
Sequence analysis of the pvhap2 gene revealed that the Y133S mutation at a high frequency in the parasite populations studied here was fixed in India, Thailand, Vietnam, China, North Korea and PNG, but was observed at lower frequencies in Colombia (26.1%), Peru (14.3%) and Mexico (46.6%) . The G1998A SNP coding for D637N was predominant in isolates from the China-Myanmar border (82.96%), Thailand (68.29%), Thailand-2014 (42.48%), Vietnam (100%), China (50%), North Korea (100%), but had a lower frequency in western Myanmar (36.54%) and was absent in isolates from Iran, India, PNG, Mauritania-I, Brazil, Colombia, Peru and Mexico . Previous reports have demonstrated the ‘cd loop’ region of HAP2 protein is essential for gamete fertilization . Of note, two non-synonymous mutations (K129N and Y133S) were found within the loop region (108–222 aa) of the Pvhap2 protein, which corresponds to the HAP2 orthologues in P. falciparum (178–195 aa) and P. berghei (174–191 aa). Only one G626A SNP (synonymous mutation, R179R) was found within the hydrophobic “fusion loop” (cd loop) segment (167–198 aa) of loop region in Pvhap2. Given the essential function of the “cd loop” in mediating membrane fusion, these results suggest that functional conservation of the same region within the HAP2 protein in P. vivax may limit the accumulation of amino acid mutations [16, 22]. Whether these mutations influence Pvhap2 function or immunogenicity needs further investigations.
The divergent prevalence of Pvhap2 mutations in different endemic areas probably reflects the different demographic histories of the parasites such as endemicity and selection imposed by the human host and mosquito vectors. In the GMS, the Y133S mutation was fixed or almost fixed, whereas the D637N mutation showed regional differences in prevalence. Difference in regional malaria epidemiology may be held accountable for this divergence in D637N prevalence. Pairwise comparison showed considerable differentiation between China-Myanmar border and western Myanmar populations. Alternatively, this divergence may reflect an evolutionary trend of the parasite populations through time, as the parasites from western Thailand (83.0%), China-Myanmar border (68.3%) and western Myanmar (36.5%) were collected in 2011, 2016 and 2018, respectively. It is possible that this longitudinal decrease in D637N prevalence may be associated with host immunity since HAP2 is shown to be naturally immunogenic and antibodies against this protein are present in endemic populations . Interestingly, codon-based selection tests detected positive selection at three codons in the western Myanmar parasites, including codon 637, suggesting potential targeting of these codons by host immunity. Of note, D637N is located in an epitope region (625–651 aa) of the Pvhap2 protein; thus, this mutation may alter the immunogenicity of the HAP2 protein. Future experiments are needed to show whether this amino acid substitution could interfere with fusion function (gamete fusion) or protein recognition by host antibodies.
Pvhap2 showed lower genetic diversity (ranging from 0.00018 to 0.00075 for all global isolates analyzed)  compared to other sexual stage transmission-blocking antigens reported in P. vivax such as pvs28/25 (π = 0.0034/0.0013, Yunnan Province of China, ; π = 0.0041/0.0023, Myanmar, ), pvs48/45 (π = 0.00173, global isolates, ), and pvs230 (π = 0.00118, global isolates, ). This high level of conservation may be a consequence of the essential function of this protein in fertilization. Although not significant, the negative value for the dN-dS in nucleotide sequences of pvhap2 gene from the GMS suggests purifying selection may act on this gene. Allele-frequency-based tests further indicate that pvhap2 was influenced by purifying selection. Further, when zoomed in specific regions of the pvhap2 gene, codons under purifying selection were identified in all three GMS parasite populations. This is similar to the gametocyte/gamete-surface antigen pvs230, which appears to be under purifying selection . Another gametocyte/gametes surface protein, pvs48/45, was found to be under positive selection . Thus, in addition to functional constraints, Pvhap2 may avoid immune selection pressure from the human host, as it is predominantly expressed by microgametes found in mosquito midgut, not in humans. Regardless, the evolutionary conservation of pvhap2 may be beneficial for the design of a TBV.
Despite the low level of sequence diversity, the overall genetic differentiation among GMS and Iran populations in this study was remarkable, which was cross-verified from FST and phylogenetic analysis. Within the GMS, however, low FST values among all GMS populations studied here may suggest extensive gene flow among these populations, possibly mediated or enhanced by migratory human populations . These results also highlight that Pvhap2-based TBV design need to factor in the geographical differentiation of pvhap2 among populations. For example, GMS parasite populations did show a highly prevalent haplotype, H2 (frequency within the GMS area: 61.67%), whereas the Sal I Pvhap2 haplotype was not observed in Myanmar (0/51), and circulates with low frequency in the China-Myanmar border (1/135) and Thailand (3/41) isolates. Although the two non-synonymous positions (E317K and D637N) that are located in the predicted B cell epitopes did not seem to change the protein configuration and B cell epitope prediction score, this awaits further experimental confirmation.
The present study revealed very low level of genetic diversity and purifying selection in pvhap2, indicating the importance of this protein in parasite’s survival and transmission. Little genetic differentiation identified among the three GMS populations suggests extensive gene flow between these areas. Notably, this study revealed a dominant haplotype (H2) of pvhap2 in GMS isolates. Additionally, the present study identified potential B-cell epitopes with relatively low diversity. These findings provide important information for designing an effective TBV based on Pvhap2.
Availability of data and materials
The datasets supporting the conclusions of this article are included within the article and its additional files. The nucleotide sequences were deposited in the GenBank database under the accession numbers MT087312-MT087446 (China-Myanmar border), MT087488-MT087538 (Myanmar) and MT087447-MT087487 (Thailand).
Greater Mekong Subregion
transmission blocking vaccine
generative cell specific 1
- Sal I:
- S :
number of segregation sites
- η :
total number of mutations
- k :
average number of nucleotide differences
number of haplotypes
- d N :
mean number of non-synonymous substitutions per non-synonymous site
- d S :
mean number of synonymous substitutions per synonymous site
analysis of molecular variance
- F ST :
single nucleotide polymorphism
Hewitt S, Delacollette C, Poirot E. Malaria control in the Greater Mekong Subregion: an overview of the current response and its limitations. Southeast Asian J Trop Med Public Health. 2013;44(Suppl. 1):249–305.
Hotez PJ, Bottazzi ME, Strych U, Chang LY, Lim YA, Goodenow MM, et al. Neglected tropical diseases among the Association of Southeast Asian Nations (ASEAN): overview and update. PLoS Negl Trop Dis. 2015;9:e0003575.
Muller O, Lu GY, von Seidlein L. Geographic expansion of artemisinin resistance. J Travel Med. 2019;26:taz030.
Hamilton WL, Amato R, van der Pluijm RW, Jacob CG, Quang HH, Thuy-Nhien NT, et al. Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study. Lancet Infect Dis. 2019;19:943–51.
Inkochasan M, Gopinath D, Vicario E, Lee A, Duigan P. Access to health care for migrants in the Greater Mekong Subregion: policies and legal frameworks and their impact on malaria control in the context of malaria elimination. WHO South East Asia J Public Health. 2019;8:26–34.
Chaumeau V, Kajeechiwa L, Fustec B, Landier J, Naw Nyo S, Nay Hsel S, et al. Contribution of asymptomatic Plasmodium infections to the transmission of malaria in Kayin State, Myanmar. J Infect Dis. 2019;219:1499–509.
WHO. World malaria report 2017. Geneva: World Health Organization; 2017. http://www.who.int/malaria/publications/world-malaria-report-2017/en. Accessed 29 Nov 2017.
Wu Y, Sinden RE, Churcher TS, Tsuboi T, Yusibov V. Development of malaria transmission-blocking vaccines: from concept to product. Adv Parasitol. 2015;89:109–52.
Hisaeda H, Yasutomo K. Development of malaria vaccines that block transmission of parasites by mosquito vectors. J Med Invest. 2002;49:118–23.
Saul A. Mosquito stage, transmission blocking vaccines for malaria. Curr Opin Infect Dis. 2007;20:476–81.
Acquah FK, Adjah J, Williamson KC, Amoah LE. Transmission-blocking vaccines: old friends and new prospects. Infect Immun. 2019;87:e00775-18.
Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12:833–40.
Hirai M, Mori T. Fertilization is a novel attacking site for the transmission blocking of malaria parasites. Acta Trop. 2010;114:157–61.
van Dijk MR, Janse CJ, Thompson J, Waters AP, Braks JA, Dodemont HJ, et al. A central role for P48/45 in malaria parasite male gamete fertility. Cell. 2001;104:153–64.
Marin-Mogollon C, van de Vegte-Bolmer M, van Gemert GJ, van Pul FJA, Ramesar J, Othman AS, et al. The Plasmodium falciparum male gametocyte protein P230p, a paralog of P230, is vital for ookinete formation and mosquito transmission. Sci Rep. 2018;8:14902.
Angrisano F, Sala KA, Da DF, Liu Y, Pei J, Grishin NV, et al. Targeting the conserved fusion loop of HAP2 inhibits the transmission of Plasmodium berghei and falciparum. Cell Rep. 2017;21:2868–78.
von Besser K, Frank AC, Johnson MA, Preuss D. Arabidopsis HAP2 (GCS1) is a sperm-specific gene required for pollen tube guidance and fertilization. Development. 2006;133:4761–9.
Mori T, Kuroiwa H, Higashiyama T, Kuroiwa T. Generative cell specific 1 is essential for angiosperm fertilization. Nat Cell Biol. 2006;8:64–71.
Liu Y, Tewari R, Ning J, Blagborough AM, Garbom S, Pei J, et al. The conserved plant sterility gene HAP2 functions after attachment of fusogenic membranes in Chlamydomonas and Plasmodium gametes. Genes Dev. 2008;22:1051–68.
Wong JL, Leydon AR, Johnson MA. HAP2(GCS1)-dependent gamete fusion requires a positively charged carboxy-terminal domain. PLoS Genet. 2010;6:e1000882.
Blagborough AM, Sinden RE. Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro. Vaccine. 2009;27:5187–94.
Fedry J, Liu Y, Pehau-Arnaudet G, Pei J, Li W, Tortorici MA, et al. The ancient gamete fusogen HAP2 is a eukaryotic class II fusion protein. Cell. 2017;168:904–15.
Pinello JF, Lai AL, Millet JK, Cassidy-Hanley D, Freed JH, Clark TG. Structure-function studies link class II viral fusogens with the ancestral gamete fusion protein HAP2. Curr Biol. 2017;27:651–60.
Miura K, Takashima E, Deng B, Tullo G, Diouf A, Moretz SE, et al. Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay. Infect Immun. 2013;81:4377–82.
Takala SL, Coulibaly D, Thera MA, Batchelor AH, Cummings MP, Escalante AA, et al. Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Sci Transl Med. 2009;1:2ra5.
Mehrizi AA, Dodangeh F, Zakeri S, Djadid ND. Worldwide population genetic analysis and natural selection in the Plasmodium vivax generative cell specific 1 (PvGCS1) as a transmission-blocking vaccine candidate. Infect Genet Evol. 2016;43:50–7.
Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35:1547–9.
Rozas J, Ferrer-Mata A, Sanchez-DelBarrio JC, Guirao-Rico S, Librado P, Ramos-Onsins SE, et al. DnaSP 6: DNA sequence polymorphism analysis of large data sets. Mol Biol Evol. 2017;34:3299–302.
Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989;123:585–95.
Fu YX, Li WH. Statistical tests of neutrality of mutations. Genetics. 1993;133:693–709.
McDonald JH, Kreitman M. Adaptive protein evolution at the Adh locus in Drosophila. Nature. 1991;351:652–4.
Delport W, Poon AF, Frost SD, Kosakovsky Pond SL. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics. 2010;26:2455–7.
Excoffier L, Lischer HE. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour. 2010;10:564–7.
Balloux F, Lugon-Moulin N. The estimation of population differentiation with microsatellite markers. Mol Ecol. 2002;11:155–65.
Bandelt HJ, Forster P, Rohl A. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 1999;16:37–48.
Saha S, Raghava GP. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins. 2006;65:40–8.
Liu W, Xie Y, Ma J, Luo X, Nie P, Zuo Z, et al. IBS: an illustrator for the presentation and visualization of biological sequences. Bioinformatics. 2015;31:3359–61.
Ren J, Wen L, Gao X, Jin C, Xue Y, Yao X. DOG 1.0: illustrator of protein domain structures. Cell Res. 2009;19:271–3.
Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10:845–58.
Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA. 2001;98:10037–41.
Kosakovsky Pond SL, Frost SD. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005;22:1208–22.
Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL, et al. FUBAR: a fast, unconstrained Bayesian approximation for inferring selection. Mol Biol Evol. 2013;30:1196–205.
Feng H, Zheng L, Zhu X, Wang G, Pan Y, Li Y, et al. Genetic diversity of transmission-blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province, China. Parasit Vectors. 2011;4:224.
Le HG, Kang JM, Jun H, Lee J, Moe M, Thai TL, et al. Genetic diversity and natural selection of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax Myanmar isolates. Acta Trop. 2019;198:105104.
Vallejo AF, Martinez NL, Tobon A, Alger J, Lacerda MV, Kajava AV, et al. Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45. Malar J. 2016;15:202.
Doi M, Tanabe K, Tachibana S, Hamai M, Tachibana M, Mita T, et al. Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax. Vaccine. 2011;29:4308–15.
Feng H, Gupta B, Wang M, Zheng W, Zheng L, Zhu X, et al. Genetic diversity of transmission-blocking vaccine candidate Pvs48/45 in Plasmodium vivax populations in China. Parasit Vectors. 2015;8:615.
Singhasivanon P. Mekong malaria. Malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia. Southeast Asian J Trop Med Public Health. 1999;30(Suppl. 4):1–101.
We would like to thank patients from the surrounding villages for participating in this study and providing the blood samples.
This study was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA (U19AI089672).
Ethics approval and consent to participate
The study protocol was approved by the ethics committees from the Department of Medical Research, Myanmar Ministry of Health and Sports, China Medical University, Mahidol University, and the University of South Florida, USA. Written informed consent/assent was obtained from all participants.
Consent for publication
The authors declare that they have no competing interests. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Geographical distribution of P. vivax populations contributing to this study. Plasmodium vivax isolates from three sampling sites, including China-Myanmar border, Myanmar and Thailand were analyzed in the present study.
List of the primers along with their nucleotide sequences used to assess the genetic diversity of the pvhap2 gene.
Pvhap2 gene polymorphism by country.
About this article
Cite this article
Li, D., Yu, C., Guo, J. et al. Plasmodium vivax HAP2/GCS1 gene exhibits limited genetic diversity among parasite isolates from the Greater Mekong Subregion. Parasites Vectors 13, 175 (2020). https://doi.org/10.1186/s13071-020-04050-0
- Plasmodium vivax
- Transmission-blocking vaccine
- Genetic diversity